Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page no longer lists 'Type 2 diabetes' as a condition and removes the related topic 'MedlinePlus Genetics'.
    Difference
    0.2%
    Check dated 2026-02-18T07:30:16.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page, and the temporary government funding/operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:56:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a general government funding notice and a site revision update: Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:48:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary option and related topics (Type 2 diabetes, MedlinePlus Genetics) were added. QC-related metadata labels were updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' and 'Revision: v3.3.4' were removed or adjusted.
    Difference
    0.4%
    Check dated 2026-01-28T00:55:58.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page lost its Type 2 diabetes topic tags and related topics such as MedlinePlus Genetics, removing key subject metadata and potentially reducing discoverability.
    Difference
    0.2%
    Check dated 2026-01-21T00:40:16.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 instead of v3.3.3; this update does not change any study details, eligibility, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T01:50:42.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.